Oragenics
OGEN
13 hedge funds and large institutions have $62.2K invested in Oragenics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0.01% less ownership
Funds ownership: 0.08% → 0.06% (-0.01%)
54% less capital invested
Capital invested by funds: $136K → $62.2K (-$73.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$26.3K |
| 2 |
GWM
GSB Wealth Management
Guilford,
Connecticut
|
+$19K |
| 3 |
LWM
Lionsbridge Wealth Management
Jacksonville Beach,
Florida
|
+$9.43K |
| 4 |
VF
Virtu Financial
New York
|
+$8.19K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$23.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.03K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$28 |
OGEN Hedge Fund Activity: Q3 2024 in Review
13 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2024, worth a combined $62.2K — down 54% from $136K a quarter earlier.
Fund positioning in OGEN was balanced in Q3 2024: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $26.3K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $23.4K sold.
- 13 institutional investors held Oragenics (OGEN) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $62.2K of Oragenics stock for Q3 2024, down 54% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q3 2024 and 4 closed out, a net change of 0 holders.
- The largest Oragenics buyer in Q3 2024 was HRT Financial, an estimated $26.3K added.
- The largest Oragenics seller in Q3 2024 was Renaissance Technologies, an estimated $23.4K sold.
Based on aggregated 13F filings for Q3 2024.